Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Triscysteine disulfide-directing motifs enabling design and discovery of multicyclic peptide binders.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Author(s): Duan Z;Duan Z; Kong C; Kong C; Fan S; Fan S; Wu C; Wu C
- Source:
Nature communications [Nat Commun] 2024 Sep 06; Vol. 15 (1), pp. 7799. Date of Electronic Publication: 2024 Sep 06.
- Publication Type:
Journal Article
- Language:
English
- Additional Information
- Source:
Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
- Publication Information:
Original Publication: [London] : Nature Pub. Group
- Subject Terms:
- Abstract:
Peptides are valuable for therapeutic development, with multicyclic peptides showing promise in mimicking antigen-binding potency of antibodies. However, our capability to engineer multicyclic peptide scaffolds, particularly for the construction of large combinatorial libraries, is still limited. Here, we study the interplay of disulfide pairing between three biscysteine motifs, and designed a range of triscysteine motifs with unique disulfide-directing capability for regulating the oxidative folding of multicyclic peptides. We demonstrate that incorporating these motifs into random sequences allows the design of disulfide-directed multicyclic peptide (DDMP) libraries with up to four disulfide bonds, which have been applied for the successful discovery of peptide binders with nanomolar affinity to several challenging targets. This study encourages the use of more diverse disulfide-directing motifs for creating multicyclic peptide libraries and opens an avenue for discovering functional peptides in sequence and structural space beyond existing peptide scaffolds, potentially advancing the field of peptide drug discovery.
(© 2024. The Author(s).)
- References:
Chem Sci. 2021 Jun 17;12(28):9694-9703. (PMID: 34349940)
Nat Chem Biol. 2018 May;14(5):417-427. (PMID: 29662187)
Chem Soc Rev. 2021 Feb 15;50(3):1480-1494. (PMID: 33346298)
Blood Adv. 2020 Oct 27;4(20):5203-5214. (PMID: 33095875)
Sci Rep. 2021 Apr 27;11(1):9091. (PMID: 33907275)
Nat Chem Biol. 2009 Jul;5(7):502-7. (PMID: 19483697)
J Pharmacol Exp Ther. 2013 Jan;344(1):196-206. (PMID: 23090647)
Curr Cancer Drug Targets. 2005 May;5(3):149-57. (PMID: 15892616)
J Med Chem. 2020 Apr 23;63(8):4107-4116. (PMID: 32202781)
Bioinformatics. 2015 Apr 15;31(8):1325-7. (PMID: 25505092)
Antioxid Redox Signal. 2009 May;11(5):971-80. (PMID: 19025420)
Nat Biotechnol. 2022 Aug;40(8):1157-1159. (PMID: 35945436)
ACS Chem Biol. 2014 Feb 21;9(2):443-50. (PMID: 24195775)
Nat Rev Drug Discov. 2021 Apr;20(4):309-325. (PMID: 33536635)
J Neurochem. 2017 Aug;142 Suppl 2:7-18. (PMID: 28326549)
Curr Opin Chem Biol. 2016 Oct;34:143-150. (PMID: 27642714)
Nature. 2017 Oct 5;550(7674):74-79. (PMID: 28953867)
Structure. 2019 Feb 5;27(2):315-326.e7. (PMID: 30554841)
Acta Crystallogr D Biol Crystallogr. 1998 Sep 1;54(Pt 5):905-21. (PMID: 9757107)
J Am Chem Soc. 2021 Nov 10;143(44):18481-18489. (PMID: 34723512)
Angew Chem Int Ed Engl. 2010 Sep 3;49(37):6545-8. (PMID: 20533477)
Bioessays. 2016 Jun;38(6):539-48. (PMID: 27166747)
Angew Chem Int Ed Engl. 2015 Nov 23;54(48):14276-81. (PMID: 26031649)
Angew Chem Int Ed Engl. 2019 Apr 1;58(15):4880-4885. (PMID: 30762292)
J Am Chem Soc. 2013 May 1;135(17):6562-9. (PMID: 23560397)
Protein Eng. 1998 Aug;11(8):649-59. (PMID: 9749917)
ACS Chem Biol. 2011 Aug 19;6(8):837-44. (PMID: 21615106)
J Am Chem Soc. 2023 Jan 25;145(3):1964-1972. (PMID: 36633218)
Chem Commun (Camb). 2018 Apr 17;54(32):4029-4032. (PMID: 29619474)
Nat Chem. 2018 Jul;10(7):715-723. (PMID: 29713035)
Nat Chem. 2012 Dec;4(12):1044-9. (PMID: 23174986)
Chem Rev. 2014 Jan 22;114(2):901-26. (PMID: 24446748)
Chem Sci. 2022 May 20;13(26):7780-7789. (PMID: 35865895)
J Biomol NMR. 1995 Nov;6(3):277-93. (PMID: 8520220)
Clin Cancer Res. 2021 Jul 1;27(13):3528-3539. (PMID: 33608318)
Acc Chem Res. 2017 Jul 18;50(7):1557-1565. (PMID: 28644007)
Free Radic Biol Med. 2012 Jan 15;52(2):444-51. (PMID: 22107959)
Nat Commun. 2022 Mar 22;13(1):1539. (PMID: 35318337)
J Am Chem Soc. 2020 Sep 23;142(38):16285-16291. (PMID: 32914969)
J Biomol NMR. 2013 Jul;56(3):227-41. (PMID: 23728592)
Proc Natl Acad Sci U S A. 2020 May 26;117(21):11399-11408. (PMID: 32398368)
Angew Chem Int Ed Engl. 2016 Aug 16;55(34):9894-7. (PMID: 27304709)
J Biomol NMR. 1996 Dec;8(4):477-86. (PMID: 9008363)
Chem Rev. 2014 Jun 11;114(11):5815-47. (PMID: 24720541)
Nat Commun. 2020 Jan 15;11(1):295. (PMID: 31941901)
Nature. 2016 Oct 20;538(7625):329-335. (PMID: 27626386)
Nat Commun. 2020 Oct 8;11(1):5066. (PMID: 33033255)
PLoS Comput Biol. 2009 Sep;5(9):e1000499. (PMID: 19730675)
J Am Chem Soc. 2023 Dec 27;145(51):28264-28275. (PMID: 38092662)
Nat Commun. 2017 Dec 21;8(1):2244. (PMID: 29269835)
J Exp Clin Cancer Res. 2022 Oct 21;41(1):310. (PMID: 36271429)
Proc Natl Acad Sci U S A. 2011 Jun 28;108(26):10478-83. (PMID: 21670253)
Proc Natl Acad Sci U S A. 2022 Nov 16;119(46):e2207327119. (PMID: 36343233)
Nat Chem Biol. 2018 Apr;14(4):375-380. (PMID: 29507389)
J Am Chem Soc. 2015 Dec 9;137(48):15094-7. (PMID: 26588670)
Bioinformatics. 2007 Feb 1;23(3):381-2. (PMID: 17121777)
ESMO Open. 2020 Jan;5(1):. (PMID: 32516116)
- Grant Information:
92356308 National Natural Science Foundation of China (National Science Foundation of China); 22174119 National Natural Science Foundation of China (National Science Foundation of China)
- Accession Number:
0 (Disulfides)
K848JZ4886 (Cysteine)
0 (Peptide Library)
0 (Peptides)
0 (Peptides, Cyclic)
- Publication Date:
Date Created: 20240906 Date Completed: 20240906 Latest Revision: 20240910
- Publication Date:
20250114
- Accession Number:
PMC11379947
- Accession Number:
10.1038/s41467-024-51723-w
- Accession Number:
39242578
No Comments.